MTST (MetaStat) Days Inventory: 0.00 (As of Feb. 2018)


What is MetaStat Days Inventory?

MetaStat MTST Days Inventory is 0.00 as of Feb. 2018.

Days Inventory is also known as Days Sales of Inventory (DSI). MetaStat's Average Total Inventories for the three months ended in Feb. 2018 was $0.00 Mil. MetaStat's Cost of Goods Sold for the three months ended in Feb. 2018 was $0.00 Mil.

The historical rank and industry rank for MetaStat's Days Inventory or its related term are showing as below:

MTST's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.97
* Ranked among companies with meaningful Days Inventory only.

MetaStat's Days Inventory stayed the same from Feb. 2017 (0.00) to Feb. 2018 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


MetaStat  (OTCPK:MTST) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

MetaStat's Inventory Turnover for the three months ended in Feb. 2018 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

MetaStat's Inventory to Revenue for the three months ended in Feb. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


MetaStat Days Inventory Related Terms


MetaStat Days Inventory Historical Data

* Premium members only.

The historical data trend for MetaStat's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat Days Inventory Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MTST vs OBMP, NSPX, ATRX: Days Inventory Comparison

For the Biotechnology subindustry, MetaStat's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MetaStat Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MetaStat's Days Inventory distribution charts can be found below:

* The bar in red indicates where MetaStat's Days Inventory falls into.



MetaStat Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

MetaStat's Days Inventory for the fiscal year that ended in Feb. 2018 is calculated as

Days Inventory (A: Feb. 2018 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Feb. 2017 ) + Total Inventories (A: Feb. 2018 )) / count ) / Cost of Goods Sold (A: Feb. 2018 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

MetaStat's Days Inventory for the quarter that ended in Feb. 2018 is calculated as:

Days Inventory (Q: Feb. 2018 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Nov. 2017 ) + Total Inventories (Q: Feb. 2018 )) / count ) / Cost of Goods Sold (Q: Feb. 2018 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
MetaStat (MTST) has a Days Inventory of 0.00 as of Feb. 2018. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MetaStat and its competitors.
Is MetaStat's Days Inventory too high?
MetaStat's current Days Inventory is 0.00.
How does MetaStat's Days Inventory compare to OBMP and NSPX?
MetaStat's Days Inventory of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 183.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.97, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MetaStat and its competitors. For the Biotechnology industry, the median Days Inventory is 183.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MetaStat's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MetaStat (MTST), the current Days Inventory is 0.00 as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.